metoclopramide

Generic: metoclopramide

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name metoclopramide
Generic Name metoclopramide
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

metoclopramide hydrochloride 5 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1288
Product ID 51662-1288_101e1ec9-a7a9-e2b4-e063-6394a90af539
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA073118
Listing Expiration 2026-12-31
Marketing Start 2018-09-22

Pharmacologic Class

Classes
dopamine d2 antagonists [moa] dopamine-2 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621288
Hyphenated Format 51662-1288

Supplemental Identifiers

RxCUI
311670
UNII
W1792A2RVD

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name metoclopramide (source: ndc)
Generic Name metoclopramide (source: ndc)
Application Number ANDA073118 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 5 mg/mL
source: ndc
Packaging
  • 2 mL in 1 VIAL, SINGLE-DOSE (51662-1288-1)
  • 25 POUCH in 1 CASE (51662-1288-3) / 1 VIAL, SINGLE-USE in 1 POUCH (51662-1288-2) / 2 mL in 1 VIAL, SINGLE-USE
source: ndc

Packages (2)

51662-1288-1 2 mL in 1 VIAL, SINGLE-DOSE (51662-1288-1) 51662-1288-3 25 POUCH in 1 CASE (51662-1288-3) / 1 VIAL, SINGLE-USE in 1 POUCH (51662-1288-2) / 2 mL in 1 VIAL, SINGLE-USE

Ingredients (1)

metoclopramide hydrochloride (5 mg/mL)

Linked Drug Pages (1)

METOCLOPRAMIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "101e1ec9-a7a9-e2b4-e063-6394a90af539", "openfda": {"unii": ["W1792A2RVD"], "rxcui": ["311670"], "spl_set_id": ["7678bcd5-1071-0a9b-e053-2a91aa0a3853"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 VIAL, SINGLE-DOSE (51662-1288-1)", "package_ndc": "51662-1288-1", "marketing_start_date": "20180922"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1288-3)  / 1 VIAL, SINGLE-USE in 1 POUCH (51662-1288-2)  / 2 mL in 1 VIAL, SINGLE-USE", "package_ndc": "51662-1288-3", "marketing_start_date": "20221001"}], "brand_name": "METOCLOPRAMIDE", "product_id": "51662-1288_101e1ec9-a7a9-e2b4-e063-6394a90af539", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Dopamine D2 Antagonists [MoA]", "Dopamine-2 Receptor Antagonist [EPC]"], "product_ndc": "51662-1288", "generic_name": "METOCLOPRAMIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "METOCLOPRAMIDE", "active_ingredients": [{"name": "METOCLOPRAMIDE HYDROCHLORIDE", "strength": "5 mg/mL"}], "application_number": "ANDA073118", "marketing_category": "ANDA", "marketing_start_date": "20180922", "listing_expiration_date": "20261231"}